Received May 20, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
became ill; chest was red raw; fever; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of unwell in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, immediately after receiving Shingrix, the patient experienced unwell (Verbatim: became ill), localized erythema (Verbatim: chest was red raw) and fever (Verbatim: fever). The outcome of the unwell, localized erythema and fever were unknown. It was unknown if the reporter considered the unwell, localized erythema and fever to be related to Shingrix. It was unknown if the company considered the unwell, localized erythema and fever to be related to Shingrix. Additional Information: GSK Receipt Date: 13-MAY-2026 The batch number was not provided upon follow- up with the reporter.